Medical Care
Global Nucleic Acid Multiplex Assays Market Research Report 2025
- Mar 11, 25
- ID: 114127
- Pages: 82
- Figures: 88
- Views: 1
The global market for Nucleic Acid Multiplex Assays was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Multiplex Nucleic Acid Assay for Identification of Microorganisms and Resistance Markers from Positive Blood Cultures - Class II Special Controls Guideline for Industry and Food and Drug Administration Staff
North American market for Nucleic Acid Multiplex Assays is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Nucleic Acid Multiplex Assays is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Nucleic Acid Multiplex Assays in Pharmaceutical & Biotechnology Companies is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Nucleic Acid Multiplex Assays include Abcam, Becton, Dickinson and Company, Merck KGaA, Agilent Technologies, Bio-Techne, Shimadzu Biotech, Thermo Fisher Scientific, Bio-Rad Laboratories, Qiagen, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Nucleic Acid Multiplex Assays, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nucleic Acid Multiplex Assays.
The Nucleic Acid Multiplex Assays market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Nucleic Acid Multiplex Assays market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Nucleic Acid Multiplex Assays companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abcam
Becton
Dickinson and Company
Merck KGaA
Agilent Technologies
Bio-Techne
Shimadzu Biotech
Thermo Fisher Scientific
Bio-Rad Laboratories
Qiagen
Luminex Corporation
Segment by Type
Planar Nucleic Acid Assays
Bead-Based Nucleic Acid Assays
Other Nucleic Acid Assays
Segment by Application
Pharmaceutical & Biotechnology Companies
Hospitals & Research Institutes
Reference Laboratories
Other End Users
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Nucleic Acid Multiplex Assays company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Multiplex Nucleic Acid Assay for Identification of Microorganisms and Resistance Markers from Positive Blood Cultures - Class II Special Controls Guideline for Industry and Food and Drug Administration Staff
North American market for Nucleic Acid Multiplex Assays is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Nucleic Acid Multiplex Assays is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Nucleic Acid Multiplex Assays in Pharmaceutical & Biotechnology Companies is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Nucleic Acid Multiplex Assays include Abcam, Becton, Dickinson and Company, Merck KGaA, Agilent Technologies, Bio-Techne, Shimadzu Biotech, Thermo Fisher Scientific, Bio-Rad Laboratories, Qiagen, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Nucleic Acid Multiplex Assays, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nucleic Acid Multiplex Assays.
The Nucleic Acid Multiplex Assays market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Nucleic Acid Multiplex Assays market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Nucleic Acid Multiplex Assays companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abcam
Becton
Dickinson and Company
Merck KGaA
Agilent Technologies
Bio-Techne
Shimadzu Biotech
Thermo Fisher Scientific
Bio-Rad Laboratories
Qiagen
Luminex Corporation
Segment by Type
Planar Nucleic Acid Assays
Bead-Based Nucleic Acid Assays
Other Nucleic Acid Assays
Segment by Application
Pharmaceutical & Biotechnology Companies
Hospitals & Research Institutes
Reference Laboratories
Other End Users
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Nucleic Acid Multiplex Assays company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Nucleic Acid Multiplex Assays Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Planar Nucleic Acid Assays
1.2.3 Bead-Based Nucleic Acid Assays
1.2.4 Other Nucleic Acid Assays
1.3 Market by Application
1.3.1 Global Nucleic Acid Multiplex Assays Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Pharmaceutical & Biotechnology Companies
1.3.3 Hospitals & Research Institutes
1.3.4 Reference Laboratories
1.3.5 Other End Users
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Nucleic Acid Multiplex Assays Market Perspective (2020-2031)
2.2 Global Nucleic Acid Multiplex Assays Growth Trends by Region
2.2.1 Global Nucleic Acid Multiplex Assays Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Nucleic Acid Multiplex Assays Historic Market Size by Region (2020-2025)
2.2.3 Nucleic Acid Multiplex Assays Forecasted Market Size by Region (2026-2031)
2.3 Nucleic Acid Multiplex Assays Market Dynamics
2.3.1 Nucleic Acid Multiplex Assays Industry Trends
2.3.2 Nucleic Acid Multiplex Assays Market Drivers
2.3.3 Nucleic Acid Multiplex Assays Market Challenges
2.3.4 Nucleic Acid Multiplex Assays Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Nucleic Acid Multiplex Assays Players by Revenue
3.1.1 Global Top Nucleic Acid Multiplex Assays Players by Revenue (2020-2025)
3.1.2 Global Nucleic Acid Multiplex Assays Revenue Market Share by Players (2020-2025)
3.2 Global Nucleic Acid Multiplex Assays Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Nucleic Acid Multiplex Assays Revenue
3.4 Global Nucleic Acid Multiplex Assays Market Concentration Ratio
3.4.1 Global Nucleic Acid Multiplex Assays Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Nucleic Acid Multiplex Assays Revenue in 2024
3.5 Global Key Players of Nucleic Acid Multiplex Assays Head office and Area Served
3.6 Global Key Players of Nucleic Acid Multiplex Assays, Product and Application
3.7 Global Key Players of Nucleic Acid Multiplex Assays, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Nucleic Acid Multiplex Assays Breakdown Data by Type
4.1 Global Nucleic Acid Multiplex Assays Historic Market Size by Type (2020-2025)
4.2 Global Nucleic Acid Multiplex Assays Forecasted Market Size by Type (2026-2031)
5 Nucleic Acid Multiplex Assays Breakdown Data by Application
5.1 Global Nucleic Acid Multiplex Assays Historic Market Size by Application (2020-2025)
5.2 Global Nucleic Acid Multiplex Assays Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Nucleic Acid Multiplex Assays Market Size (2020-2031)
6.2 North America Nucleic Acid Multiplex Assays Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Nucleic Acid Multiplex Assays Market Size by Country (2020-2025)
6.4 North America Nucleic Acid Multiplex Assays Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Nucleic Acid Multiplex Assays Market Size (2020-2031)
7.2 Europe Nucleic Acid Multiplex Assays Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Nucleic Acid Multiplex Assays Market Size by Country (2020-2025)
7.4 Europe Nucleic Acid Multiplex Assays Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Nucleic Acid Multiplex Assays Market Size (2020-2031)
8.2 Asia-Pacific Nucleic Acid Multiplex Assays Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Nucleic Acid Multiplex Assays Market Size by Region (2020-2025)
8.4 Asia-Pacific Nucleic Acid Multiplex Assays Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Nucleic Acid Multiplex Assays Market Size (2020-2031)
9.2 Latin America Nucleic Acid Multiplex Assays Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Nucleic Acid Multiplex Assays Market Size by Country (2020-2025)
9.4 Latin America Nucleic Acid Multiplex Assays Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Nucleic Acid Multiplex Assays Market Size (2020-2031)
10.2 Middle East & Africa Nucleic Acid Multiplex Assays Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Nucleic Acid Multiplex Assays Market Size by Country (2020-2025)
10.4 Middle East & Africa Nucleic Acid Multiplex Assays Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abcam
11.1.1 Abcam Company Details
11.1.2 Abcam Business Overview
11.1.3 Abcam Nucleic Acid Multiplex Assays Introduction
11.1.4 Abcam Revenue in Nucleic Acid Multiplex Assays Business (2020-2025)
11.1.5 Abcam Recent Development
11.2 Becton
11.2.1 Becton Company Details
11.2.2 Becton Business Overview
11.2.3 Becton Nucleic Acid Multiplex Assays Introduction
11.2.4 Becton Revenue in Nucleic Acid Multiplex Assays Business (2020-2025)
11.2.5 Becton Recent Development
11.3 Dickinson and Company
11.3.1 Dickinson and Company Company Details
11.3.2 Dickinson and Company Business Overview
11.3.3 Dickinson and Company Nucleic Acid Multiplex Assays Introduction
11.3.4 Dickinson and Company Revenue in Nucleic Acid Multiplex Assays Business (2020-2025)
11.3.5 Dickinson and Company Recent Development
11.4 Merck KGaA
11.4.1 Merck KGaA Company Details
11.4.2 Merck KGaA Business Overview
11.4.3 Merck KGaA Nucleic Acid Multiplex Assays Introduction
11.4.4 Merck KGaA Revenue in Nucleic Acid Multiplex Assays Business (2020-2025)
11.4.5 Merck KGaA Recent Development
11.5 Agilent Technologies
11.5.1 Agilent Technologies Company Details
11.5.2 Agilent Technologies Business Overview
11.5.3 Agilent Technologies Nucleic Acid Multiplex Assays Introduction
11.5.4 Agilent Technologies Revenue in Nucleic Acid Multiplex Assays Business (2020-2025)
11.5.5 Agilent Technologies Recent Development
11.6 Bio-Techne
11.6.1 Bio-Techne Company Details
11.6.2 Bio-Techne Business Overview
11.6.3 Bio-Techne Nucleic Acid Multiplex Assays Introduction
11.6.4 Bio-Techne Revenue in Nucleic Acid Multiplex Assays Business (2020-2025)
11.6.5 Bio-Techne Recent Development
11.7 Shimadzu Biotech
11.7.1 Shimadzu Biotech Company Details
11.7.2 Shimadzu Biotech Business Overview
11.7.3 Shimadzu Biotech Nucleic Acid Multiplex Assays Introduction
11.7.4 Shimadzu Biotech Revenue in Nucleic Acid Multiplex Assays Business (2020-2025)
11.7.5 Shimadzu Biotech Recent Development
11.8 Thermo Fisher Scientific
11.8.1 Thermo Fisher Scientific Company Details
11.8.2 Thermo Fisher Scientific Business Overview
11.8.3 Thermo Fisher Scientific Nucleic Acid Multiplex Assays Introduction
11.8.4 Thermo Fisher Scientific Revenue in Nucleic Acid Multiplex Assays Business (2020-2025)
11.8.5 Thermo Fisher Scientific Recent Development
11.9 Bio-Rad Laboratories
11.9.1 Bio-Rad Laboratories Company Details
11.9.2 Bio-Rad Laboratories Business Overview
11.9.3 Bio-Rad Laboratories Nucleic Acid Multiplex Assays Introduction
11.9.4 Bio-Rad Laboratories Revenue in Nucleic Acid Multiplex Assays Business (2020-2025)
11.9.5 Bio-Rad Laboratories Recent Development
11.10 Qiagen
11.10.1 Qiagen Company Details
11.10.2 Qiagen Business Overview
11.10.3 Qiagen Nucleic Acid Multiplex Assays Introduction
11.10.4 Qiagen Revenue in Nucleic Acid Multiplex Assays Business (2020-2025)
11.10.5 Qiagen Recent Development
11.11 Luminex Corporation
11.11.1 Luminex Corporation Company Details
11.11.2 Luminex Corporation Business Overview
11.11.3 Luminex Corporation Nucleic Acid Multiplex Assays Introduction
11.11.4 Luminex Corporation Revenue in Nucleic Acid Multiplex Assays Business (2020-2025)
11.11.5 Luminex Corporation Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Nucleic Acid Multiplex Assays Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Planar Nucleic Acid Assays
1.2.3 Bead-Based Nucleic Acid Assays
1.2.4 Other Nucleic Acid Assays
1.3 Market by Application
1.3.1 Global Nucleic Acid Multiplex Assays Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Pharmaceutical & Biotechnology Companies
1.3.3 Hospitals & Research Institutes
1.3.4 Reference Laboratories
1.3.5 Other End Users
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Nucleic Acid Multiplex Assays Market Perspective (2020-2031)
2.2 Global Nucleic Acid Multiplex Assays Growth Trends by Region
2.2.1 Global Nucleic Acid Multiplex Assays Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Nucleic Acid Multiplex Assays Historic Market Size by Region (2020-2025)
2.2.3 Nucleic Acid Multiplex Assays Forecasted Market Size by Region (2026-2031)
2.3 Nucleic Acid Multiplex Assays Market Dynamics
2.3.1 Nucleic Acid Multiplex Assays Industry Trends
2.3.2 Nucleic Acid Multiplex Assays Market Drivers
2.3.3 Nucleic Acid Multiplex Assays Market Challenges
2.3.4 Nucleic Acid Multiplex Assays Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Nucleic Acid Multiplex Assays Players by Revenue
3.1.1 Global Top Nucleic Acid Multiplex Assays Players by Revenue (2020-2025)
3.1.2 Global Nucleic Acid Multiplex Assays Revenue Market Share by Players (2020-2025)
3.2 Global Nucleic Acid Multiplex Assays Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Nucleic Acid Multiplex Assays Revenue
3.4 Global Nucleic Acid Multiplex Assays Market Concentration Ratio
3.4.1 Global Nucleic Acid Multiplex Assays Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Nucleic Acid Multiplex Assays Revenue in 2024
3.5 Global Key Players of Nucleic Acid Multiplex Assays Head office and Area Served
3.6 Global Key Players of Nucleic Acid Multiplex Assays, Product and Application
3.7 Global Key Players of Nucleic Acid Multiplex Assays, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Nucleic Acid Multiplex Assays Breakdown Data by Type
4.1 Global Nucleic Acid Multiplex Assays Historic Market Size by Type (2020-2025)
4.2 Global Nucleic Acid Multiplex Assays Forecasted Market Size by Type (2026-2031)
5 Nucleic Acid Multiplex Assays Breakdown Data by Application
5.1 Global Nucleic Acid Multiplex Assays Historic Market Size by Application (2020-2025)
5.2 Global Nucleic Acid Multiplex Assays Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Nucleic Acid Multiplex Assays Market Size (2020-2031)
6.2 North America Nucleic Acid Multiplex Assays Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Nucleic Acid Multiplex Assays Market Size by Country (2020-2025)
6.4 North America Nucleic Acid Multiplex Assays Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Nucleic Acid Multiplex Assays Market Size (2020-2031)
7.2 Europe Nucleic Acid Multiplex Assays Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Nucleic Acid Multiplex Assays Market Size by Country (2020-2025)
7.4 Europe Nucleic Acid Multiplex Assays Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Nucleic Acid Multiplex Assays Market Size (2020-2031)
8.2 Asia-Pacific Nucleic Acid Multiplex Assays Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Nucleic Acid Multiplex Assays Market Size by Region (2020-2025)
8.4 Asia-Pacific Nucleic Acid Multiplex Assays Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Nucleic Acid Multiplex Assays Market Size (2020-2031)
9.2 Latin America Nucleic Acid Multiplex Assays Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Nucleic Acid Multiplex Assays Market Size by Country (2020-2025)
9.4 Latin America Nucleic Acid Multiplex Assays Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Nucleic Acid Multiplex Assays Market Size (2020-2031)
10.2 Middle East & Africa Nucleic Acid Multiplex Assays Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Nucleic Acid Multiplex Assays Market Size by Country (2020-2025)
10.4 Middle East & Africa Nucleic Acid Multiplex Assays Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abcam
11.1.1 Abcam Company Details
11.1.2 Abcam Business Overview
11.1.3 Abcam Nucleic Acid Multiplex Assays Introduction
11.1.4 Abcam Revenue in Nucleic Acid Multiplex Assays Business (2020-2025)
11.1.5 Abcam Recent Development
11.2 Becton
11.2.1 Becton Company Details
11.2.2 Becton Business Overview
11.2.3 Becton Nucleic Acid Multiplex Assays Introduction
11.2.4 Becton Revenue in Nucleic Acid Multiplex Assays Business (2020-2025)
11.2.5 Becton Recent Development
11.3 Dickinson and Company
11.3.1 Dickinson and Company Company Details
11.3.2 Dickinson and Company Business Overview
11.3.3 Dickinson and Company Nucleic Acid Multiplex Assays Introduction
11.3.4 Dickinson and Company Revenue in Nucleic Acid Multiplex Assays Business (2020-2025)
11.3.5 Dickinson and Company Recent Development
11.4 Merck KGaA
11.4.1 Merck KGaA Company Details
11.4.2 Merck KGaA Business Overview
11.4.3 Merck KGaA Nucleic Acid Multiplex Assays Introduction
11.4.4 Merck KGaA Revenue in Nucleic Acid Multiplex Assays Business (2020-2025)
11.4.5 Merck KGaA Recent Development
11.5 Agilent Technologies
11.5.1 Agilent Technologies Company Details
11.5.2 Agilent Technologies Business Overview
11.5.3 Agilent Technologies Nucleic Acid Multiplex Assays Introduction
11.5.4 Agilent Technologies Revenue in Nucleic Acid Multiplex Assays Business (2020-2025)
11.5.5 Agilent Technologies Recent Development
11.6 Bio-Techne
11.6.1 Bio-Techne Company Details
11.6.2 Bio-Techne Business Overview
11.6.3 Bio-Techne Nucleic Acid Multiplex Assays Introduction
11.6.4 Bio-Techne Revenue in Nucleic Acid Multiplex Assays Business (2020-2025)
11.6.5 Bio-Techne Recent Development
11.7 Shimadzu Biotech
11.7.1 Shimadzu Biotech Company Details
11.7.2 Shimadzu Biotech Business Overview
11.7.3 Shimadzu Biotech Nucleic Acid Multiplex Assays Introduction
11.7.4 Shimadzu Biotech Revenue in Nucleic Acid Multiplex Assays Business (2020-2025)
11.7.5 Shimadzu Biotech Recent Development
11.8 Thermo Fisher Scientific
11.8.1 Thermo Fisher Scientific Company Details
11.8.2 Thermo Fisher Scientific Business Overview
11.8.3 Thermo Fisher Scientific Nucleic Acid Multiplex Assays Introduction
11.8.4 Thermo Fisher Scientific Revenue in Nucleic Acid Multiplex Assays Business (2020-2025)
11.8.5 Thermo Fisher Scientific Recent Development
11.9 Bio-Rad Laboratories
11.9.1 Bio-Rad Laboratories Company Details
11.9.2 Bio-Rad Laboratories Business Overview
11.9.3 Bio-Rad Laboratories Nucleic Acid Multiplex Assays Introduction
11.9.4 Bio-Rad Laboratories Revenue in Nucleic Acid Multiplex Assays Business (2020-2025)
11.9.5 Bio-Rad Laboratories Recent Development
11.10 Qiagen
11.10.1 Qiagen Company Details
11.10.2 Qiagen Business Overview
11.10.3 Qiagen Nucleic Acid Multiplex Assays Introduction
11.10.4 Qiagen Revenue in Nucleic Acid Multiplex Assays Business (2020-2025)
11.10.5 Qiagen Recent Development
11.11 Luminex Corporation
11.11.1 Luminex Corporation Company Details
11.11.2 Luminex Corporation Business Overview
11.11.3 Luminex Corporation Nucleic Acid Multiplex Assays Introduction
11.11.4 Luminex Corporation Revenue in Nucleic Acid Multiplex Assays Business (2020-2025)
11.11.5 Luminex Corporation Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Nucleic Acid Multiplex Assays Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Planar Nucleic Acid Assays
Table 3. Key Players of Bead-Based Nucleic Acid Assays
Table 4. Key Players of Other Nucleic Acid Assays
Table 5. Global Nucleic Acid Multiplex Assays Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Nucleic Acid Multiplex Assays Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Nucleic Acid Multiplex Assays Market Size by Region (2020-2025) & (US$ Million)
Table 8. Global Nucleic Acid Multiplex Assays Market Share by Region (2020-2025)
Table 9. Global Nucleic Acid Multiplex Assays Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 10. Global Nucleic Acid Multiplex Assays Market Share by Region (2026-2031)
Table 11. Nucleic Acid Multiplex Assays Market Trends
Table 12. Nucleic Acid Multiplex Assays Market Drivers
Table 13. Nucleic Acid Multiplex Assays Market Challenges
Table 14. Nucleic Acid Multiplex Assays Market Restraints
Table 15. Global Nucleic Acid Multiplex Assays Revenue by Players (2020-2025) & (US$ Million)
Table 16. Global Nucleic Acid Multiplex Assays Market Share by Players (2020-2025)
Table 17. Global Top Nucleic Acid Multiplex Assays Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nucleic Acid Multiplex Assays as of 2024)
Table 18. Ranking of Global Top Nucleic Acid Multiplex Assays Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by Nucleic Acid Multiplex Assays Revenue (CR5 and HHI) & (2020-2025)
Table 20. Global Key Players of Nucleic Acid Multiplex Assays, Headquarters and Area Served
Table 21. Global Key Players of Nucleic Acid Multiplex Assays, Product and Application
Table 22. Global Key Players of Nucleic Acid Multiplex Assays, Date of Enter into This Industry
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Nucleic Acid Multiplex Assays Market Size by Type (2020-2025) & (US$ Million)
Table 25. Global Nucleic Acid Multiplex Assays Revenue Market Share by Type (2020-2025)
Table 26. Global Nucleic Acid Multiplex Assays Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 27. Global Nucleic Acid Multiplex Assays Revenue Market Share by Type (2026-2031)
Table 28. Global Nucleic Acid Multiplex Assays Market Size by Application (2020-2025) & (US$ Million)
Table 29. Global Nucleic Acid Multiplex Assays Revenue Market Share by Application (2020-2025)
Table 30. Global Nucleic Acid Multiplex Assays Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 31. Global Nucleic Acid Multiplex Assays Revenue Market Share by Application (2026-2031)
Table 32. North America Nucleic Acid Multiplex Assays Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 33. North America Nucleic Acid Multiplex Assays Market Size by Country (2020-2025) & (US$ Million)
Table 34. North America Nucleic Acid Multiplex Assays Market Size by Country (2026-2031) & (US$ Million)
Table 35. Europe Nucleic Acid Multiplex Assays Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. Europe Nucleic Acid Multiplex Assays Market Size by Country (2020-2025) & (US$ Million)
Table 37. Europe Nucleic Acid Multiplex Assays Market Size by Country (2026-2031) & (US$ Million)
Table 38. Asia-Pacific Nucleic Acid Multiplex Assays Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 39. Asia-Pacific Nucleic Acid Multiplex Assays Market Size by Region (2020-2025) & (US$ Million)
Table 40. Asia-Pacific Nucleic Acid Multiplex Assays Market Size by Region (2026-2031) & (US$ Million)
Table 41. Latin America Nucleic Acid Multiplex Assays Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 42. Latin America Nucleic Acid Multiplex Assays Market Size by Country (2020-2025) & (US$ Million)
Table 43. Latin America Nucleic Acid Multiplex Assays Market Size by Country (2026-2031) & (US$ Million)
Table 44. Middle East & Africa Nucleic Acid Multiplex Assays Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Middle East & Africa Nucleic Acid Multiplex Assays Market Size by Country (2020-2025) & (US$ Million)
Table 46. Middle East & Africa Nucleic Acid Multiplex Assays Market Size by Country (2026-2031) & (US$ Million)
Table 47. Abcam Company Details
Table 48. Abcam Business Overview
Table 49. Abcam Nucleic Acid Multiplex Assays Product
Table 50. Abcam Revenue in Nucleic Acid Multiplex Assays Business (2020-2025) & (US$ Million)
Table 51. Abcam Recent Development
Table 52. Becton Company Details
Table 53. Becton Business Overview
Table 54. Becton Nucleic Acid Multiplex Assays Product
Table 55. Becton Revenue in Nucleic Acid Multiplex Assays Business (2020-2025) & (US$ Million)
Table 56. Becton Recent Development
Table 57. Dickinson and Company Company Details
Table 58. Dickinson and Company Business Overview
Table 59. Dickinson and Company Nucleic Acid Multiplex Assays Product
Table 60. Dickinson and Company Revenue in Nucleic Acid Multiplex Assays Business (2020-2025) & (US$ Million)
Table 61. Dickinson and Company Recent Development
Table 62. Merck KGaA Company Details
Table 63. Merck KGaA Business Overview
Table 64. Merck KGaA Nucleic Acid Multiplex Assays Product
Table 65. Merck KGaA Revenue in Nucleic Acid Multiplex Assays Business (2020-2025) & (US$ Million)
Table 66. Merck KGaA Recent Development
Table 67. Agilent Technologies Company Details
Table 68. Agilent Technologies Business Overview
Table 69. Agilent Technologies Nucleic Acid Multiplex Assays Product
Table 70. Agilent Technologies Revenue in Nucleic Acid Multiplex Assays Business (2020-2025) & (US$ Million)
Table 71. Agilent Technologies Recent Development
Table 72. Bio-Techne Company Details
Table 73. Bio-Techne Business Overview
Table 74. Bio-Techne Nucleic Acid Multiplex Assays Product
Table 75. Bio-Techne Revenue in Nucleic Acid Multiplex Assays Business (2020-2025) & (US$ Million)
Table 76. Bio-Techne Recent Development
Table 77. Shimadzu Biotech Company Details
Table 78. Shimadzu Biotech Business Overview
Table 79. Shimadzu Biotech Nucleic Acid Multiplex Assays Product
Table 80. Shimadzu Biotech Revenue in Nucleic Acid Multiplex Assays Business (2020-2025) & (US$ Million)
Table 81. Shimadzu Biotech Recent Development
Table 82. Thermo Fisher Scientific Company Details
Table 83. Thermo Fisher Scientific Business Overview
Table 84. Thermo Fisher Scientific Nucleic Acid Multiplex Assays Product
Table 85. Thermo Fisher Scientific Revenue in Nucleic Acid Multiplex Assays Business (2020-2025) & (US$ Million)
Table 86. Thermo Fisher Scientific Recent Development
Table 87. Bio-Rad Laboratories Company Details
Table 88. Bio-Rad Laboratories Business Overview
Table 89. Bio-Rad Laboratories Nucleic Acid Multiplex Assays Product
Table 90. Bio-Rad Laboratories Revenue in Nucleic Acid Multiplex Assays Business (2020-2025) & (US$ Million)
Table 91. Bio-Rad Laboratories Recent Development
Table 92. Qiagen Company Details
Table 93. Qiagen Business Overview
Table 94. Qiagen Nucleic Acid Multiplex Assays Product
Table 95. Qiagen Revenue in Nucleic Acid Multiplex Assays Business (2020-2025) & (US$ Million)
Table 96. Qiagen Recent Development
Table 97. Luminex Corporation Company Details
Table 98. Luminex Corporation Business Overview
Table 99. Luminex Corporation Nucleic Acid Multiplex Assays Product
Table 100. Luminex Corporation Revenue in Nucleic Acid Multiplex Assays Business (2020-2025) & (US$ Million)
Table 101. Luminex Corporation Recent Development
Table 102. Research Programs/Design for This Report
Table 103. Key Data Information from Secondary Sources
Table 104. Key Data Information from Primary Sources
Table 105. Authors List of This Report
List of Figures
Figure 1. Nucleic Acid Multiplex Assays Picture
Figure 2. Global Nucleic Acid Multiplex Assays Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Nucleic Acid Multiplex Assays Market Share by Type: 2024 VS 2031
Figure 4. Planar Nucleic Acid Assays Features
Figure 5. Bead-Based Nucleic Acid Assays Features
Figure 6. Other Nucleic Acid Assays Features
Figure 7. Global Nucleic Acid Multiplex Assays Market Size by Application (2020-2031) & (US$ Million)
Figure 8. Global Nucleic Acid Multiplex Assays Market Share by Application: 2024 VS 2031
Figure 9. Pharmaceutical & Biotechnology Companies Case Studies
Figure 10. Hospitals & Research Institutes Case Studies
Figure 11. Reference Laboratories Case Studies
Figure 12. Other End Users Case Studies
Figure 13. Nucleic Acid Multiplex Assays Report Years Considered
Figure 14. Global Nucleic Acid Multiplex Assays Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 15. Global Nucleic Acid Multiplex Assays Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Nucleic Acid Multiplex Assays Market Share by Region: 2024 VS 2031
Figure 17. Global Nucleic Acid Multiplex Assays Market Share by Players in 2024
Figure 18. Global Top Nucleic Acid Multiplex Assays Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nucleic Acid Multiplex Assays as of 2024)
Figure 19. The Top 10 and 5 Players Market Share by Nucleic Acid Multiplex Assays Revenue in 2024
Figure 20. North America Nucleic Acid Multiplex Assays Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. North America Nucleic Acid Multiplex Assays Market Share by Country (2020-2031)
Figure 22. United States Nucleic Acid Multiplex Assays Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Canada Nucleic Acid Multiplex Assays Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Nucleic Acid Multiplex Assays Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Nucleic Acid Multiplex Assays Market Share by Country (2020-2031)
Figure 26. Germany Nucleic Acid Multiplex Assays Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. France Nucleic Acid Multiplex Assays Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. U.K. Nucleic Acid Multiplex Assays Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Italy Nucleic Acid Multiplex Assays Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Russia Nucleic Acid Multiplex Assays Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Nordic Countries Nucleic Acid Multiplex Assays Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Nucleic Acid Multiplex Assays Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Nucleic Acid Multiplex Assays Market Share by Region (2020-2031)
Figure 34. China Nucleic Acid Multiplex Assays Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Japan Nucleic Acid Multiplex Assays Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. South Korea Nucleic Acid Multiplex Assays Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Southeast Asia Nucleic Acid Multiplex Assays Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. India Nucleic Acid Multiplex Assays Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Australia Nucleic Acid Multiplex Assays Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Nucleic Acid Multiplex Assays Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Nucleic Acid Multiplex Assays Market Share by Country (2020-2031)
Figure 42. Mexico Nucleic Acid Multiplex Assays Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Brazil Nucleic Acid Multiplex Assays Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Nucleic Acid Multiplex Assays Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Nucleic Acid Multiplex Assays Market Share by Country (2020-2031)
Figure 46. Turkey Nucleic Acid Multiplex Assays Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Saudi Arabia Nucleic Acid Multiplex Assays Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. UAE Nucleic Acid Multiplex Assays Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Abcam Revenue Growth Rate in Nucleic Acid Multiplex Assays Business (2020-2025)
Figure 50. Becton Revenue Growth Rate in Nucleic Acid Multiplex Assays Business (2020-2025)
Figure 51. Dickinson and Company Revenue Growth Rate in Nucleic Acid Multiplex Assays Business (2020-2025)
Figure 52. Merck KGaA Revenue Growth Rate in Nucleic Acid Multiplex Assays Business (2020-2025)
Figure 53. Agilent Technologies Revenue Growth Rate in Nucleic Acid Multiplex Assays Business (2020-2025)
Figure 54. Bio-Techne Revenue Growth Rate in Nucleic Acid Multiplex Assays Business (2020-2025)
Figure 55. Shimadzu Biotech Revenue Growth Rate in Nucleic Acid Multiplex Assays Business (2020-2025)
Figure 56. Thermo Fisher Scientific Revenue Growth Rate in Nucleic Acid Multiplex Assays Business (2020-2025)
Figure 57. Bio-Rad Laboratories Revenue Growth Rate in Nucleic Acid Multiplex Assays Business (2020-2025)
Figure 58. Qiagen Revenue Growth Rate in Nucleic Acid Multiplex Assays Business (2020-2025)
Figure 59. Luminex Corporation Revenue Growth Rate in Nucleic Acid Multiplex Assays Business (2020-2025)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Table 1. Global Nucleic Acid Multiplex Assays Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Planar Nucleic Acid Assays
Table 3. Key Players of Bead-Based Nucleic Acid Assays
Table 4. Key Players of Other Nucleic Acid Assays
Table 5. Global Nucleic Acid Multiplex Assays Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Nucleic Acid Multiplex Assays Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Nucleic Acid Multiplex Assays Market Size by Region (2020-2025) & (US$ Million)
Table 8. Global Nucleic Acid Multiplex Assays Market Share by Region (2020-2025)
Table 9. Global Nucleic Acid Multiplex Assays Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 10. Global Nucleic Acid Multiplex Assays Market Share by Region (2026-2031)
Table 11. Nucleic Acid Multiplex Assays Market Trends
Table 12. Nucleic Acid Multiplex Assays Market Drivers
Table 13. Nucleic Acid Multiplex Assays Market Challenges
Table 14. Nucleic Acid Multiplex Assays Market Restraints
Table 15. Global Nucleic Acid Multiplex Assays Revenue by Players (2020-2025) & (US$ Million)
Table 16. Global Nucleic Acid Multiplex Assays Market Share by Players (2020-2025)
Table 17. Global Top Nucleic Acid Multiplex Assays Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nucleic Acid Multiplex Assays as of 2024)
Table 18. Ranking of Global Top Nucleic Acid Multiplex Assays Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by Nucleic Acid Multiplex Assays Revenue (CR5 and HHI) & (2020-2025)
Table 20. Global Key Players of Nucleic Acid Multiplex Assays, Headquarters and Area Served
Table 21. Global Key Players of Nucleic Acid Multiplex Assays, Product and Application
Table 22. Global Key Players of Nucleic Acid Multiplex Assays, Date of Enter into This Industry
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Nucleic Acid Multiplex Assays Market Size by Type (2020-2025) & (US$ Million)
Table 25. Global Nucleic Acid Multiplex Assays Revenue Market Share by Type (2020-2025)
Table 26. Global Nucleic Acid Multiplex Assays Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 27. Global Nucleic Acid Multiplex Assays Revenue Market Share by Type (2026-2031)
Table 28. Global Nucleic Acid Multiplex Assays Market Size by Application (2020-2025) & (US$ Million)
Table 29. Global Nucleic Acid Multiplex Assays Revenue Market Share by Application (2020-2025)
Table 30. Global Nucleic Acid Multiplex Assays Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 31. Global Nucleic Acid Multiplex Assays Revenue Market Share by Application (2026-2031)
Table 32. North America Nucleic Acid Multiplex Assays Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 33. North America Nucleic Acid Multiplex Assays Market Size by Country (2020-2025) & (US$ Million)
Table 34. North America Nucleic Acid Multiplex Assays Market Size by Country (2026-2031) & (US$ Million)
Table 35. Europe Nucleic Acid Multiplex Assays Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. Europe Nucleic Acid Multiplex Assays Market Size by Country (2020-2025) & (US$ Million)
Table 37. Europe Nucleic Acid Multiplex Assays Market Size by Country (2026-2031) & (US$ Million)
Table 38. Asia-Pacific Nucleic Acid Multiplex Assays Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 39. Asia-Pacific Nucleic Acid Multiplex Assays Market Size by Region (2020-2025) & (US$ Million)
Table 40. Asia-Pacific Nucleic Acid Multiplex Assays Market Size by Region (2026-2031) & (US$ Million)
Table 41. Latin America Nucleic Acid Multiplex Assays Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 42. Latin America Nucleic Acid Multiplex Assays Market Size by Country (2020-2025) & (US$ Million)
Table 43. Latin America Nucleic Acid Multiplex Assays Market Size by Country (2026-2031) & (US$ Million)
Table 44. Middle East & Africa Nucleic Acid Multiplex Assays Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Middle East & Africa Nucleic Acid Multiplex Assays Market Size by Country (2020-2025) & (US$ Million)
Table 46. Middle East & Africa Nucleic Acid Multiplex Assays Market Size by Country (2026-2031) & (US$ Million)
Table 47. Abcam Company Details
Table 48. Abcam Business Overview
Table 49. Abcam Nucleic Acid Multiplex Assays Product
Table 50. Abcam Revenue in Nucleic Acid Multiplex Assays Business (2020-2025) & (US$ Million)
Table 51. Abcam Recent Development
Table 52. Becton Company Details
Table 53. Becton Business Overview
Table 54. Becton Nucleic Acid Multiplex Assays Product
Table 55. Becton Revenue in Nucleic Acid Multiplex Assays Business (2020-2025) & (US$ Million)
Table 56. Becton Recent Development
Table 57. Dickinson and Company Company Details
Table 58. Dickinson and Company Business Overview
Table 59. Dickinson and Company Nucleic Acid Multiplex Assays Product
Table 60. Dickinson and Company Revenue in Nucleic Acid Multiplex Assays Business (2020-2025) & (US$ Million)
Table 61. Dickinson and Company Recent Development
Table 62. Merck KGaA Company Details
Table 63. Merck KGaA Business Overview
Table 64. Merck KGaA Nucleic Acid Multiplex Assays Product
Table 65. Merck KGaA Revenue in Nucleic Acid Multiplex Assays Business (2020-2025) & (US$ Million)
Table 66. Merck KGaA Recent Development
Table 67. Agilent Technologies Company Details
Table 68. Agilent Technologies Business Overview
Table 69. Agilent Technologies Nucleic Acid Multiplex Assays Product
Table 70. Agilent Technologies Revenue in Nucleic Acid Multiplex Assays Business (2020-2025) & (US$ Million)
Table 71. Agilent Technologies Recent Development
Table 72. Bio-Techne Company Details
Table 73. Bio-Techne Business Overview
Table 74. Bio-Techne Nucleic Acid Multiplex Assays Product
Table 75. Bio-Techne Revenue in Nucleic Acid Multiplex Assays Business (2020-2025) & (US$ Million)
Table 76. Bio-Techne Recent Development
Table 77. Shimadzu Biotech Company Details
Table 78. Shimadzu Biotech Business Overview
Table 79. Shimadzu Biotech Nucleic Acid Multiplex Assays Product
Table 80. Shimadzu Biotech Revenue in Nucleic Acid Multiplex Assays Business (2020-2025) & (US$ Million)
Table 81. Shimadzu Biotech Recent Development
Table 82. Thermo Fisher Scientific Company Details
Table 83. Thermo Fisher Scientific Business Overview
Table 84. Thermo Fisher Scientific Nucleic Acid Multiplex Assays Product
Table 85. Thermo Fisher Scientific Revenue in Nucleic Acid Multiplex Assays Business (2020-2025) & (US$ Million)
Table 86. Thermo Fisher Scientific Recent Development
Table 87. Bio-Rad Laboratories Company Details
Table 88. Bio-Rad Laboratories Business Overview
Table 89. Bio-Rad Laboratories Nucleic Acid Multiplex Assays Product
Table 90. Bio-Rad Laboratories Revenue in Nucleic Acid Multiplex Assays Business (2020-2025) & (US$ Million)
Table 91. Bio-Rad Laboratories Recent Development
Table 92. Qiagen Company Details
Table 93. Qiagen Business Overview
Table 94. Qiagen Nucleic Acid Multiplex Assays Product
Table 95. Qiagen Revenue in Nucleic Acid Multiplex Assays Business (2020-2025) & (US$ Million)
Table 96. Qiagen Recent Development
Table 97. Luminex Corporation Company Details
Table 98. Luminex Corporation Business Overview
Table 99. Luminex Corporation Nucleic Acid Multiplex Assays Product
Table 100. Luminex Corporation Revenue in Nucleic Acid Multiplex Assays Business (2020-2025) & (US$ Million)
Table 101. Luminex Corporation Recent Development
Table 102. Research Programs/Design for This Report
Table 103. Key Data Information from Secondary Sources
Table 104. Key Data Information from Primary Sources
Table 105. Authors List of This Report
List of Figures
Figure 1. Nucleic Acid Multiplex Assays Picture
Figure 2. Global Nucleic Acid Multiplex Assays Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Nucleic Acid Multiplex Assays Market Share by Type: 2024 VS 2031
Figure 4. Planar Nucleic Acid Assays Features
Figure 5. Bead-Based Nucleic Acid Assays Features
Figure 6. Other Nucleic Acid Assays Features
Figure 7. Global Nucleic Acid Multiplex Assays Market Size by Application (2020-2031) & (US$ Million)
Figure 8. Global Nucleic Acid Multiplex Assays Market Share by Application: 2024 VS 2031
Figure 9. Pharmaceutical & Biotechnology Companies Case Studies
Figure 10. Hospitals & Research Institutes Case Studies
Figure 11. Reference Laboratories Case Studies
Figure 12. Other End Users Case Studies
Figure 13. Nucleic Acid Multiplex Assays Report Years Considered
Figure 14. Global Nucleic Acid Multiplex Assays Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 15. Global Nucleic Acid Multiplex Assays Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Nucleic Acid Multiplex Assays Market Share by Region: 2024 VS 2031
Figure 17. Global Nucleic Acid Multiplex Assays Market Share by Players in 2024
Figure 18. Global Top Nucleic Acid Multiplex Assays Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nucleic Acid Multiplex Assays as of 2024)
Figure 19. The Top 10 and 5 Players Market Share by Nucleic Acid Multiplex Assays Revenue in 2024
Figure 20. North America Nucleic Acid Multiplex Assays Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. North America Nucleic Acid Multiplex Assays Market Share by Country (2020-2031)
Figure 22. United States Nucleic Acid Multiplex Assays Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Canada Nucleic Acid Multiplex Assays Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Nucleic Acid Multiplex Assays Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Nucleic Acid Multiplex Assays Market Share by Country (2020-2031)
Figure 26. Germany Nucleic Acid Multiplex Assays Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. France Nucleic Acid Multiplex Assays Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. U.K. Nucleic Acid Multiplex Assays Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Italy Nucleic Acid Multiplex Assays Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Russia Nucleic Acid Multiplex Assays Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Nordic Countries Nucleic Acid Multiplex Assays Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Nucleic Acid Multiplex Assays Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Nucleic Acid Multiplex Assays Market Share by Region (2020-2031)
Figure 34. China Nucleic Acid Multiplex Assays Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Japan Nucleic Acid Multiplex Assays Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. South Korea Nucleic Acid Multiplex Assays Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Southeast Asia Nucleic Acid Multiplex Assays Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. India Nucleic Acid Multiplex Assays Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Australia Nucleic Acid Multiplex Assays Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Nucleic Acid Multiplex Assays Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Nucleic Acid Multiplex Assays Market Share by Country (2020-2031)
Figure 42. Mexico Nucleic Acid Multiplex Assays Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Brazil Nucleic Acid Multiplex Assays Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Nucleic Acid Multiplex Assays Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Nucleic Acid Multiplex Assays Market Share by Country (2020-2031)
Figure 46. Turkey Nucleic Acid Multiplex Assays Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Saudi Arabia Nucleic Acid Multiplex Assays Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. UAE Nucleic Acid Multiplex Assays Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Abcam Revenue Growth Rate in Nucleic Acid Multiplex Assays Business (2020-2025)
Figure 50. Becton Revenue Growth Rate in Nucleic Acid Multiplex Assays Business (2020-2025)
Figure 51. Dickinson and Company Revenue Growth Rate in Nucleic Acid Multiplex Assays Business (2020-2025)
Figure 52. Merck KGaA Revenue Growth Rate in Nucleic Acid Multiplex Assays Business (2020-2025)
Figure 53. Agilent Technologies Revenue Growth Rate in Nucleic Acid Multiplex Assays Business (2020-2025)
Figure 54. Bio-Techne Revenue Growth Rate in Nucleic Acid Multiplex Assays Business (2020-2025)
Figure 55. Shimadzu Biotech Revenue Growth Rate in Nucleic Acid Multiplex Assays Business (2020-2025)
Figure 56. Thermo Fisher Scientific Revenue Growth Rate in Nucleic Acid Multiplex Assays Business (2020-2025)
Figure 57. Bio-Rad Laboratories Revenue Growth Rate in Nucleic Acid Multiplex Assays Business (2020-2025)
Figure 58. Qiagen Revenue Growth Rate in Nucleic Acid Multiplex Assays Business (2020-2025)
Figure 59. Luminex Corporation Revenue Growth Rate in Nucleic Acid Multiplex Assays Business (2020-2025)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Circuit Simulator Market Research Report 2025
Mar 11, 25
Global Schematic Editor Market Research Report 2025
Mar 11, 25
Global Milk Green Tea Market Research Report 2025
Mar 11, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232